Prodrugs of an inhibitor of HIV protease
US5733907A · kind A · utility
12Cited by
12References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 27, 1996 |
| Grant date | Mar 31, 1998 |
| Priority date | — |
| Expiry date | Mar 27, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Prodrugs of the HIV protease inhibitor L-735,524 are useful in the inhibition of HIV protease, the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating ADS and methods of preventing or treating infection by HIV are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.